While many are concerned with the efficacy of Covid-19 vaccines, The FDA has approved Monoclonal Antibody (mAB) Therapy to treat those who have tested positive and are at high risk. This promising therapy will help this group to battle Covid-19 and recover better. This one-time infusion has been reviewed and results show it can slow or stop the progression of the infection and lessen the need for hospitalization. The links below will offer more information about the therapy.

Monoclonal Antibody Treatment

This therapy is NOT without risks, The National Institute of Health has produced an article about the side effects and use risks.

NIH info

This new treatment and others will be leading the way to minimize the severity of the Covid-19 virus as well as other health issues.

NIH PubMed Article

You need to be a member of TransplantFriends.com to add comments!

Join TransplantFriends.com

Email me when people reply –

Facebook & instagram

TransplantBuddies & Friends Facebook Group

TransplantBuddies & Friends

Transplant Stories

Members Stories

Twitter

COTA

Lung Transplant Foundation

Cystic Fibrosis.com

        Organ Donation Surprising Facts

Latest Activity

Kidneyboy’s discussion was featured
Saturday
Kidneyboy’s discussion was featured via Latest Activity on TransplantFriends.com
Saturday
Kidneyboy posted a discussion
Friday
Kidneyboy posted a discussion via Latest Activity on TransplantFriends.com
Friday
More…

Planetary Biosciences for Cystic Fibrosis

Please Donate for CF Patients